Diagnos Laboratorium Utama Tbk. vs Duta Pertiwi Tbk — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 308B, 24.4K 24h volume), while Duta Pertiwi Tbk trades at Rp4,090 (market cap 7.57T, 600 24h volume). The key difference: Duta Pertiwi Tbk is far larger — about 24.6× Diagnos Laboratorium Utama Tbk.'s market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (24.4K versus 600). Which is the better fit depends on your goals.
| DGNS | DUTI | |
|---|---|---|
Market Cap | 308B | 7.57T |
Volume | 24.4K | 600 |
Lot | 244 | 6 |
Turnover | 5.54M | 2.45M |
Average Price | 227.25 | 4,090 |
Value | 5.54M | 2.45M |
Indicative Equilibrium Price | 230 | 4,090 |
Indicative Equilibrium Volume | 110 | 600 |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT. Duta Pertiwi Tbk (the Company) was established based on Notarial Deed No. 237 dated December 29, 1972 of Mohamad Said Tadjoedin, S.H., a public notary in Jakarta. The Company operates and engaged in commercial mixed use development (i.e. shophouse, kiosk/small retail space, strata office space) as well as housing, shopping center, apartment, and hotel developments.
Read more on DUTI →